Candel Therapeutics, Inc.
CADL
$4.91
-$0.13-2.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -161.74% | -134.97% | -165.00% | 152.43% | -32.19% |
| Total Depreciation and Amortization | -16.41% | -19.42% | -1.22% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 1,152.38% | -34.38% | -27.27% | -15.38% | -16.13% |
| Total Other Non-Cash Items | 3,133.62% | 110.39% | 69.32% | -300.29% | 147.06% |
| Change in Net Operating Assets | 909.83% | 431.34% | 103.67% | -345.63% | -11.97% |
| Cash from Operations | -3.24% | -15.13% | -3.19% | -48.19% | 11.55% |
| Capital Expenditure | -184.03% | -364.52% | -933.33% | 0.00% | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -249.57% | -277.42% | -933.33% | 0.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -69.32% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 3,065.71% | -99.33% | 2,160.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | 1,402.14% | -119.32% | 1,032.83% | -102.03% | 5,380.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 339.86% | -261.04% | 181.25% | -112.18% | 1,858.50% |